Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MOHAMED ELMOUELHI

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1003902545
CMS profile
1075208
Location
DAYTON, OH

General Payments · PY2018–2020

$44,032.22

  • Reported across 32 records
  • CMS publication 2026-01-23

Latest program year · PY2020

$7,250.83

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2020 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $6,700.00 6
Travel and Lodging $467.39 5
Food and Beverage $83.44 3

By paying entity

PY2020 · sorted by reported total

Paying entityAmountRecords
SANOFI-AVENTIS U.S. LLC $4,950.00 2
MITSUBISHI TANABE PHARMA DEVELOPMENT AMERICA, INC. $1,750.00 4
Eli Lilly and Company $550.83 8

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $30,737.48 14
PY2019 $6,043.91 4
PY2020 $7,250.83 14

Payment records · PY2020 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2020 20182019 Record-level detail is published for PY2020; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Eli Lilly and Company $148.59 03/04/2020 Travel and Lodging Undisputed 01/23/2026 728554567 CMS
Eli Lilly and Company $72.80 03/04/2020 Travel and Lodging Undisputed 01/23/2026 728571515 CMS
Eli Lilly and Company $84.00 03/05/2020 Travel and Lodging Undisputed 01/23/2026 728557997 CMS
Eli Lilly and Company $2.89 03/05/2020 Food and Beverage Undisputed 01/23/2026 728557999 CMS
Eli Lilly and Company $78.00 03/05/2020 Travel and Lodging Undisputed 01/23/2026 728558001 CMS
Eli Lilly and Company $84.00 03/05/2020 Travel and Lodging Undisputed 01/23/2026 728564841 CMS
Eli Lilly and Company $45.12 03/05/2020 Food and Beverage Undisputed 01/23/2026 728571517 CMS
Eli Lilly and Company $35.43 03/11/2020 Food and Beverage Undisputed 01/23/2026 728554565 CMS
Mitsubishi Tanabe Pharma Development America, Inc. $437.50 09/15/2020 Consulting Fee Undisputed 01/23/2026 750563819 CMS
Mitsubishi Tanabe Pharma Development America, Inc. $437.50 09/15/2020 Consulting Fee Undisputed 01/23/2026 750563827 CMS
Mitsubishi Tanabe Pharma Development America, Inc. $437.50 09/15/2020 Consulting Fee Undisputed 01/23/2026 750563849 CMS
Mitsubishi Tanabe Pharma Development America, Inc. $437.50 09/15/2020 Consulting Fee Undisputed 01/23/2026 750563853 CMS
SANOFI-AVENTIS U.S. LLC $3,795.00 01/13/2020 Consulting Fee Undisputed 01/23/2026 744165453 CMS
SANOFI-AVENTIS U.S. LLC $1,155.00 01/20/2020 Consulting Fee Undisputed 01/23/2026 744165455 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020
Generated from
OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.